Sara D. Allstadt

713 total citations
18 papers, 411 citations indexed

About

Sara D. Allstadt is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Small Animals. According to data from OpenAlex, Sara D. Allstadt has authored 18 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Genetics and 6 papers in Small Animals. Recurrent topics in Sara D. Allstadt's work include Veterinary Oncology Research (12 papers), Virus-based gene therapy research (7 papers) and Infectious Diseases and Mycology (4 papers). Sara D. Allstadt is often cited by papers focused on Veterinary Oncology Research (12 papers), Virus-based gene therapy research (7 papers) and Infectious Diseases and Mycology (4 papers). Sara D. Allstadt collaborates with scholars based in United States, France and Spain. Sara D. Allstadt's co-authors include Katherine A. Skorupski, Carlos O. Rodriguez, Robert B. Rebhun, Michael S. Kent, Claire M. Cannon, Christopher M. Reilly, Laura D. Garrett, Sandra Collette, William Vernau and Annette Smith and has published in prestigious journals such as Molecular Therapy, Molecular Cancer Therapeutics and Human Gene Therapy.

In The Last Decade

Sara D. Allstadt

18 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara D. Allstadt United States 12 319 174 150 53 53 18 411
Paola Laganga Italy 11 318 1.0× 109 0.6× 162 1.1× 58 1.1× 38 0.7× 18 399
Kristen Weishaar United States 10 367 1.2× 123 0.7× 205 1.4× 63 1.2× 54 1.0× 26 476
Soumi Samuel India 4 302 0.9× 127 0.7× 168 1.1× 31 0.6× 76 1.4× 14 408
Mary Lynn Higginbotham United States 13 328 1.0× 93 0.5× 166 1.1× 83 1.6× 57 1.1× 24 419
Susan Plaza United States 7 305 1.0× 114 0.7× 105 0.7× 52 1.0× 38 0.7× 7 375
Keijiro Shiomitsu United States 10 225 0.7× 70 0.4× 90 0.6× 61 1.2× 63 1.2× 32 335
Paola Valenti Italy 9 303 0.9× 70 0.4× 177 1.2× 39 0.7× 33 0.6× 24 353
Cecilia Robat United States 11 226 0.7× 75 0.4× 115 0.8× 53 1.0× 28 0.5× 20 314
Andrea B. Flory United States 12 397 1.2× 162 0.9× 248 1.7× 30 0.6× 32 0.6× 20 438
Beth Overley United States 13 433 1.4× 223 1.3× 190 1.3× 53 1.0× 77 1.5× 13 589

Countries citing papers authored by Sara D. Allstadt

Since Specialization
Citations

This map shows the geographic impact of Sara D. Allstadt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara D. Allstadt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara D. Allstadt more than expected).

Fields of papers citing papers by Sara D. Allstadt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara D. Allstadt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara D. Allstadt. The network helps show where Sara D. Allstadt may publish in the future.

Co-authorship network of co-authors of Sara D. Allstadt

This figure shows the co-authorship network connecting the top 25 collaborators of Sara D. Allstadt. A scholar is included among the top collaborators of Sara D. Allstadt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara D. Allstadt. Sara D. Allstadt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Naik, Shruthi, Amber Miller, Sara D. Allstadt, et al.. (2017). Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer. Molecular Cancer Therapeutics. 17(1). 316–326. 42 indexed citations
2.
Pollard, Rachel E., et al.. (2017). Association between environmental factors including second‐hand smoke and primary lung cancer in dogs. Journal of Small Animal Practice. 59(6). 343–349. 11 indexed citations
3.
Evans, Barbara J., et al.. (2017). Treatment outcomes and prognostic factors of feline splenic mast cell tumors: A multi‐institutional retrospective study of 64 cases. Veterinary and Comparative Oncology. 16(1). 20–27. 13 indexed citations
4.
Allstadt, Sara D., et al.. (2015). Randomized Phase III Trial of Piroxicam in Combination with Mitoxantrone or Carboplatin for First-Line Treatment of Urogenital Tract Transitional Cell Carcinoma in Dogs. Journal of Veterinary Internal Medicine. 29(1). 261–267. 45 indexed citations
5.
Cannon, Claire M. & Sara D. Allstadt. (2015). Lower Urinary Tract Cancer. Veterinary Clinics of North America Small Animal Practice. 45(4). 807–824. 14 indexed citations
6.
Collette, Sandra, Sara D. Allstadt, William Vernau, et al.. (2015). Treatment of feline intermediate‐ to high‐grade lymphoma with a modified university of Wisconsin–Madison protocol: 119 cases (2004–2012). Veterinary and Comparative Oncology. 14(S1). 136–146. 61 indexed citations
7.
Allstadt, Sara D., Timothy M. Fan, Chand Khanna, et al.. (2015). Pharmacokinetics of orally administered low-dose rapamycin in healthy dogs. American Journal of Veterinary Research. 77(1). 65–71. 11 indexed citations
8.
Naik, Shruthi, Amy K. LeBlanc, Sara D. Allstadt, et al.. (2015). 70. Safety, Toxicity and Efficacy of Systemic Recombinant VSV Therapy in Pet Dogs With Spontaneous Cancer. Molecular Therapy. 23. S30–S31. 1 indexed citations
9.
Naik, Shruthi, Sara D. Allstadt, Megan L. Steele, et al.. (2014). Early findings from a comparative oncology study evaluating systemic VSV therapy in client-owned dogs with spontaneous hematologic malignancies. Human Gene Therapy. 25(12). 1 indexed citations
10.
Skorupski, Katherine A., et al.. (2014). Presumed solitary intraocular or conjunctival lymphoma in dogs and cats: 9 cases (1985–2013). Journal of the American Veterinary Medical Association. 244(4). 460–470. 14 indexed citations
11.
Skorupski, Katherine A., et al.. (2013). Aggressive local therapy combined with systemic chemotherapy provides long‐term control in gradeIIstage 2 canine mast cell tumour: 21 cases (1999–2012). Veterinary and Comparative Oncology. 13(3). 267–280. 29 indexed citations
12.
Skorupski, Katherine A., et al.. (2013). Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phaseIIItrial. Veterinary and Comparative Oncology. 14(1). 81–87. 61 indexed citations
13.
Allstadt, Sara D., et al.. (2012). Phase I clinical trial of oral rosiglitazone in combination with intravenous carboplatin in cancer‐bearing dogs. Veterinary and Comparative Oncology. 12(1). 1–9. 4 indexed citations
14.
Allstadt, Sara D., et al.. (2011). Evaluation of an extractionless high-performance liquid chromatography-tandem mass spectrometry method for detection and quantitation of rosiglitazone in canine plasma. American Journal of Veterinary Research. 72(2). 263–270. 2 indexed citations
15.
Allstadt, Sara D., J. Ortega, Allison L. Zwingenberger, et al.. (2011). Outcome in dogs with surgically resected oral fibrosarcoma (1997–2008)*. Veterinary and Comparative Oncology. 10(1). 33–43. 27 indexed citations
16.
Allstadt, Sara D.. (2011). Phase I study of rosiglitazone in combination with carboplatin in cancer bearing dogs. 1 indexed citations
17.
Rebhun, Robert B., et al.. (2010). CHOP chemotherapy for the treatment of canine multicentric T‐cell lymphoma. Veterinary and Comparative Oncology. 9(1). 38–44. 73 indexed citations
18.
Allstadt, Sara D.. (2010). A Simple and Extractionless High-Performance Liquid Chromatography-Tandem-Mass Spectrometry (HPLC-MS/MS) Method for the Detection and Quantitation of Rosiglitazone in Canine Plasma. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Laganga Breakdown of academic impact, for papers by Kristen Weishaar Breakdown of academic impact, for papers by Soumi Samuel Breakdown of academic impact, for papers by Mary Lynn Higginbotham Breakdown of academic impact, for papers by Susan Plaza Breakdown of academic impact, for papers by Keijiro Shiomitsu Breakdown of academic impact, for papers by Paola Valenti Breakdown of academic impact, for papers by Cecilia Robat Breakdown of academic impact, for papers by Andrea B. Flory Breakdown of academic impact, for papers by Beth Overley
Rankless by CCL
2026